ILF2 anticorps (N-Term)

N° du produit ABIN1881458

Détail du produit anti-ILF2 anticorps

Antigène: ILF2 (Interleukin Enhancer Binding Factor 2, 45kDa (ILF2))

Épitope: AA 84-112, N-Term

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp ILF2 est non-conjugé

Application: Western Blotting (WB)

Homologie: M

Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogène: This ILF2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 84-112 amino acids from the N-terminal region of human ILF2.

Clone: RB42341

Isotype: Ig Fraction

Information d'application

Indications d'application: WB: 1:1000

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Date de péremption: 6 months

Références pour anticorps anti-ILF2 (ABIN1881458)

Karmakar, Mahajan, Schulz, Boyapaty, Weissman: "A multiprotein complex necessary for both transcription and DNA replication at the β-globin locus." dans: The EMBO journal, Vol. 29, Issue 19, pp. 3260-71, (2010) (PubMed).

Graber, Baird, Kao, Mathews, Holcik: "NF45 functions as an IRES trans-acting factor that is required for translation of cIAP1 during the unfolded protein response." dans: Cell death and differentiation, Vol. 17, Issue 4, pp. 719-29, (2010) (PubMed).

Davila, Froeling, Tan, Bonnard, Boland, Snippe, Hibberd, Seielstad: "New genetic associations detected in a host response study to hepatitis B vaccine." dans: Genes and immunity, Vol. 11, Issue 3, pp. 232-8, (2010) (PubMed).

Kiesler, Haynes, Shi, Kao, Wysocki, Vercelli: "NF45 and NF90 regulate HS4-dependent interleukin-13 transcription in T cells." dans: The Journal of biological chemistry, Vol. 285, Issue 11, pp. 8256-67, (2010) (PubMed).

Sakamoto, Aoki, Higuchi, Todaka, Morisawa, Tamaki, Hatano, Fukushima, Taniguchi, Agata: "The NF90-NF45 complex functions as a negative regulator in the microRNA processing pathway." dans: Molecular and cellular biology, Vol. 29, Issue 13, pp. 3754-69, (2009) (PubMed).

Détails sur ILF2

Antigène: ILF2 (Interleukin Enhancer Binding Factor 2, 45kDa (ILF2))

Autre désignation: ILF2 (ILF2 Produits)

Synonymes: anticorps nf45, anticorps pro3063, anticorps ILF2, anticorps wu:fb34h01, anticorps zgc:73084, anticorps zgc:77276, anticorps NF45, anticorps PRO3063, anticorps 6230405A16Rik, anticorps TEG-267, anticorps Tex261, anticorps Tex267, anticorps interleukin enhancer binding factor 2, anticorps interleukin enhancer binding factor 2 L homeolog, anticorps ilf2, anticorps ILF2, anticorps ilf2.L, anticorps Ilf2

Sujet: Nuclear factor of activated T-cells (NFAT) is a transcription factor required for T-cell expression of the interleukin 2 gene. NFAT binds to a sequence in the interleukin 2 gene enhancer known as the antigen receptor response element 2. In addition, NFAT can bind RNA and is an essential component for encapsidation and protein priming of hepatitis B viral polymerase. NFAT is a heterodimer of 45 kDa and 90 kDa proteins, the smaller of which is the product of this gene. The encoded protein binds strongly to the 90 kDa protein and stimulates its ability to enhance gene expression.

Poids moléculaire: 43062

NCBI Accession: NP_001254738, NP_004506

UniProt: Q12905